Literature DB >> 6380505

Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus.

A Alcover, J Molano, J Renart, A Gil-Aguado, A Nieto, J Avila.   

Abstract

Sera from patients with systemic lupus erythematosus and from healthy subjects were tested, using immunofluorescence and blotting techniques, for the presence of antibodies to intermediate filaments of the cytoskeleton of human skin fibroblasts. Both techniques showed that antibodies to intermediate filaments were found in a higher proportion of sera from patients (53%) than healthy subjects (9%). The antigen target was found to be the protein band that corresponded to vimentin (Mr 57,000).

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6380505     DOI： 10.1002/art.1780270812

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


  14 in total

1.  Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus.

Authors:  E C De Mendonca Neto; A Kumar; N A Shadick; A M Michon; P Matsudaira; R B Eaton; P Kumar; P H Schur
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

2.  The structure of two IgMs showing different activity from a patient with Waldenstrom's macroglobulinaemia.

Authors:  E Méndez; C Osuna; A Sánchez; Y Revilla; F Soriano; C Montalbán; J Seguí; J Avila
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

3.  Inhibiting effect of charged polymers on interaction of human lupus autoantibodies with certain intracellular proteins.

Authors:  A E Kabakov; L N Brovkina; A M Poverenny; L Cebecauer
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

4.  Detection of antivimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.

Authors:  Y Yang; J Fujita; S Bandoh; Y Ohtsuki; I Yamadori; T Yoshinouchi; T Ishida
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

5.  Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.

Authors:  K T Coppieters; N Amirian; M G von Herrath
Journal:  Clin Exp Immunol       Date:  2011-05-23       Impact factor: 4.330

6.  Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosus.

Authors:  M A Blaschek; M Boehme; J Jouquan; A M Simitzis; S Fifas; P Le Goff; P Youinou
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

7.  Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.

Authors:  R M Hoet; A M Boerbooms; M Arends; D J Ruiter; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

8.  Human vimentin autoantibodies preferentially interact with a peptide of 30kD mol. wt, located close to the amino-terminal of the molecule.

Authors:  A Alcover; C Hernández; J Avila
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

9.  Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.

Authors:  J G Wilson; R M Jack; W W Wong; P H Schur; D T Fearon
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

10.  Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus-associated chronic liver diseases.

Authors:  C A von Mühlen; E K Chan; C L Peebles; H Imai; K Kiyosawa; E M Tan
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.